• Dyne Therapeutics granted inducement equity awards to 17 newly hired employees.
• Non-statutory stock options cover 296,500 shares, priced at the May 20 closing price on the Nasdaq Global Select Market; the options have a 10-year term.
• The options vest over four years, with 25% vesting on the first anniversary of the employee’s start date; the balance vests quarterly.
• Restricted stock units cover 94,100 shares; vesting occurs in four equal annual installments over four years from the employee’s start date.
• The awards fall under Dyne’s 2024 Inducement Stock Incentive Plan.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dyne Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605201730PRIMZONEFULLFEED9724212) on May 20, 2026, and is solely responsible for the information contained therein.